Dermata Therapeutics, Inc.
DRMA
$5.50
-$0.33-5.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.70M | -2.30M | -3.15M | -3.17M | -2.83M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.20K | 37.20K | 29.80K | 21.00K | 19.60K |
| Change in Net Operating Assets | -1.03M | 332.30K | 207.50K | -266.80K | 683.50K |
| Cash from Operations | -2.69M | -1.93M | -2.91M | -3.42M | -2.13M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 8.54M | -- | 4.55M | 2.41M |
| Repurchase of Common Stock | -547.90K | -- | -68.60K | 0.00 | -800.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -50.50K | -- | 70.00K | -70.00K |
| Cash from Financing | -547.90K | 8.49M | -68.60K | 4.62M | 2.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.24M | 6.56M | -2.98M | 1.20M | 213.40K |